{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:24:29Z","timestamp":1767140669379,"version":"build-2238731810"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Boehringer Ingelheim, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Astellas Pharma, AstraZeneca, Daiichi Sankyo, Novartis Pharma, MSD, Sanofi-Aventis and Takeda Pharmaceutical."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00380-018-1194-5","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T11:17:02Z","timestamp":1527160622000},"page":"1534-1546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry"],"prefix":"10.1007","volume":"33","author":[{"given":"Yoshimori","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Esato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritake","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutoyo","family":"Masunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikari","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"1194_CR1","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"DG Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management I (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825\u20131833","journal-title":"N Engl J Med"},{"key":"1194_CR2","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa021375","volume":"347","author":"IC Gelder Van","year":"2002","unstructured":"Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study G (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834\u20131840","journal-title":"N Engl J Med"},{"key":"1194_CR3","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","volume":"358","author":"D Roy","year":"2008","unstructured":"Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O\u2019Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial F, Congestive Heart Failure I (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667\u20132677","journal-title":"N Engl J Med"},{"key":"1194_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jama.2009.2029","volume":"303","author":"DJ Wilber","year":"2010","unstructured":"Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, ThermoCool AFTI (2010) Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303:333\u2013340","journal-title":"JAMA"},{"key":"1194_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jama.2014.467","volume":"311","author":"CA Morillo","year":"2014","unstructured":"Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS, Natale A, Investigators R (2014) Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA 311:692\u2013700","journal-title":"JAMA"},{"key":"1194_CR6","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","volume":"61","author":"DG Jones","year":"2013","unstructured":"Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61:1894\u20131903","journal-title":"J Am Coll Cardiol"},{"key":"1194_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","volume":"7","author":"RJ Hunter","year":"2014","unstructured":"Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, Goromonzi F, Sawhney V, Duncan E, Page SP, Ullah W, Unsworth B, Mayet J, Dhinoja M, Earley MJ, Sporton S, Schilling RJ (2014) A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol 7:31\u201338","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1194_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1540-8167.2011.02035.x","volume":"22","author":"TJ Bunch","year":"2011","unstructured":"Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD (2011) Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 22:839\u2013845","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1194_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCEP.113.000597","volume":"7","author":"CH Chang","year":"2014","unstructured":"Chang CH, Lin JW, Chiu FC, Caffrey JL, Wu LC, Lai MS (2014) Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis. Circ Arrhythm Electrophysiol 7:76\u201382","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1194_CR10","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","volume":"37","author":"L Friberg","year":"2016","unstructured":"Friberg L, Tabrizi F, Englund A (2016) Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J 37:2478\u20132487","journal-title":"Eur Heart J"},{"key":"1194_CR11","doi-asserted-by":"publisher","first-page":"e0147536","DOI":"10.1371\/journal.pone.0147536","volume":"11","author":"CE Chiang","year":"2016","unstructured":"Chiang CE, Naditch-Brule L, Brette S, Silva-Cardoso J, Gamra H, Murin J, Zharinov OJ, Steg PG (2016) Atrial fibrillation management strategies in routine clinical practice: insights from the international RealiseAF survey. PLoS ONE 11:e0147536","journal-title":"PLoS ONE"},{"key":"1194_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jjcc.2012.12.002","volume":"61","author":"M Akao","year":"2013","unstructured":"Akao M, Chun YH, Wada H, Esato M, Hashimoto T, Abe M, Hasegawa K, Tsuji H, Furuke K, Fushimi AFRI (2013) Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry. J Cardiol 61:260\u2013266","journal-title":"J Cardiol"},{"key":"1194_CR13","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1253\/circj.CJ-14-0344","volume":"78","author":"M Akao","year":"2014","unstructured":"Akao M, Chun YH, Esato M, Abe M, Tsuji H, Wada H, Hasegawa K, Fushimi AFRI (2014) Inappropriate use of oral anticoagulants for patients with atrial fibrillation. Circ J 78:2166\u20132172","journal-title":"Circ J"},{"key":"1194_CR14","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1161\/STROKEAHA.115.010947","volume":"46","author":"K Takabayashi","year":"2015","unstructured":"Takabayashi K, Hamatani Y, Yamashita Y, Takagi D, Unoki T, Ishii M, Iguchi M, Masunaga N, Ogawa H, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GY, Akao M (2015) Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry. Stroke 46:3354\u20133361","journal-title":"Stroke"},{"key":"1194_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.amjcard.2012.04.049","volume":"110","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T (2012) A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation. Am J Cardiol 110:678\u2013682","journal-title":"Am J Cardiol"},{"key":"1194_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/eurjhf\/hft041","volume":"15","author":"RB Schnabel","year":"2013","unstructured":"Schnabel RB, Rienstra M, Sullivan LM, Sun JX, Moser CB, Levy D, Pencina MJ, Fontes JD, Magnani JW, McManus DD, Lubitz SA, Tadros TM, Wang TJ, Ellinor PT, Vasan RS, Benjamin EJ (2013) Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail 15:843\u2013849","journal-title":"Eur J Heart Fail"},{"key":"1194_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"1194_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","volume":"109","author":"SD Corley","year":"2004","unstructured":"Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, Investigators A (2004) Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109:1509\u20131513","journal-title":"Circulation"},{"key":"1194_CR19","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.112.092494","volume":"126","author":"MA Tsadok","year":"2012","unstructured":"Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Pilote L (2012) Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 126:2680\u20132687","journal-title":"Circulation"},{"key":"1194_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/archinternmed.2012.2266","volume":"172","author":"R Ionescu-Ittu","year":"2012","unstructured":"Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, Essebag V, Eisenberg MJ, Wynant W, Richard H, Pilote L (2012) Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med 172:997\u20131004","journal-title":"Arch Intern Med"},{"key":"1194_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.amjcard.2013.02.056","volume":"112","author":"YY Zhang","year":"2013","unstructured":"Zhang YY, Qiu C, Davis PJ, Jhaveri M, Prystowsky EN, Kowey P, Weintraub WS (2013) Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-United States cohort. Am J Cardiol 112:79\u201384","journal-title":"Am J Cardiol"},{"key":"1194_CR22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jacc.2017.12.060","volume":"71","author":"RD Lopes","year":"2018","unstructured":"Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L, Committees A and Investigators (2018) Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol 71:1063\u20131074","journal-title":"J Am Coll Cardiol"},{"key":"1194_CR23","first-page":"e199","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, Members AATF (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:e199\u2013e267","journal-title":"Circulation"},{"key":"1194_CR24","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/europace\/eup363","volume":"11","author":"S Miyazaki","year":"2009","unstructured":"Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, Isobe M, Takahashi A (2009) Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation. Europace 11:1620\u20131623","journal-title":"Europace"},{"key":"1194_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jjcc.2015.09.012","volume":"68","author":"T Kondo","year":"2016","unstructured":"Kondo T, Miake J, Kato M, Ogura K, Iitsuka K, Yamamoto K (2016) Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation. J Cardiol 68:229\u2013235","journal-title":"J Cardiol"},{"key":"1194_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bansch D, Investigators C-A (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417\u2013427","journal-title":"N Engl J Med"},{"key":"1194_CR27","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.hrthm.2014.05.003","volume":"11","author":"H Ghanbari","year":"2014","unstructured":"Ghanbari H, Baser K, Jongnarangsin K, Chugh A, Nallamothu BK, Gillespie BW, Baser HD, Suwanagool A, Crawford T, Latchamsetty R, Good E, Pelosi F Jr, Bogun F, Morady F, Oral H (2014) Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm 11:1503\u20131511","journal-title":"Heart Rhythm"},{"key":"1194_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.amjcard.2016.09.009","volume":"119","author":"YH Darrat","year":"2017","unstructured":"Darrat YH, Shah J, Elayi CS, Morales GX, Naditch-Brule L, Brette S, Taniou C, Kowey PR, Schwartz PJ (2017) Regional lack of consistency in the management of atrial fibrillation (from the RECORD-AF Trial). Am J Cardiol 119:47\u201351","journal-title":"Am J Cardiol"},{"key":"1194_CR29","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","volume":"37","author":"JP Bassand","year":"2016","unstructured":"Bassand JP, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Ten Cate H, Turpie AG, Verheugt FW, Kakkar AK, Investigators G-A (2016) Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J 37:2882\u20132889","journal-title":"Eur Heart J"}],"updated-by":[{"DOI":"10.1007\/s00380-018-1212-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000}}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-018-1194-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1194-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1194-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:22:36Z","timestamp":1558639356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-018-1194-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1007\/s00380-018-1194-5","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of the article, the data of Body mass index\u2009\u2265\u200925 (kg\/m\n                      \n                      )\n                      \n                      is published incorrectly in Table\u00a01. Since this is categorical variable, the data should have been expressed as a number (percentage), not as mean\u2009\u00b1\u2009standard deviation. The corrected version of Table\u00a01 is as below,","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Akao received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare and Daiichi Sankyo. Dr Lip has served as a consultant for Bayer, Merck, Sanofi, BMS\/Pfizer, Daiichi Sankyo, Biotronik, Medtronic, Portola and Boehringer Ingelheim and has been on the speakers bureau for Bayer, BMS\/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}